Profil
Andrew Young is the founder of Satiogen Pharmaceuticals, Inc. (founded in 2007) and Phoundry Pharmaceuticals, Inc. (founded in 2015, where he also holds the title of Director & Chief Scientific Officer).
He previously worked as Vice President-Research at Amylin Pharmaceuticals, Inc., as a Professor-Physiology Department at Auckland University, and as a Clinical Research Scientist at the National Institutes of Health from 1984 to 1987.
Dr. Young received his graduate and doctorate degrees from Auckland University.
Aktiva positioner av Andrew Young
| Företag | Position | Start |
|---|---|---|
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Grundare | 2015-01-01 |
Tidigare kända positioner av Andrew Young
| Företag | Position | Slut |
|---|---|---|
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Teknisk/Vetenskaplig/F&U Direktör | 1987-01-01 |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Grundare | - |
Auckland University
Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Teknisk/Vetenskaplig/F&U Direktör | - |
Andrew Youngs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes medicines for diabetes, obesity and cardiovascular diseases | Health Technology |
Auckland University
Auckland University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
National Institutes of Health
National Institutes of Health General GovernmentGovernment Engages in the improvement of health and saving lives | Government |
Satiogen Pharmaceuticals, Inc.
Satiogen Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Develops novel therapeutic treatments for diabetes and obesity | Commercial Services |
Phoundry Pharmaceuticals, Inc.
Phoundry Pharmaceuticals, Inc. BiotechnologyHealth Technology Engages in the discovery of peptide therapeutics | Health Technology |
















